New Multiple Sclerosis Study Reveals Protein’s Role in Disease Activation
In a new study entitled “Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation,”…
Articles by Patricia Inacio, PhD
Generic Form of Glatiramer Acetate Has Equivalent Gene Expression Profile as Teva’s Copaxone
In a recent study entitled “Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®,” authors determined potential differences…
Ocrelizumab: Could Genentech/Roche’s Experimental Drug Be the First Effective Progressive MS Therapy?
Roche announced positive results for three pivotal Phase III studies of experimental MS therapy ocrelizumab…
ECTRIMS Highlights Latest Developments in Multiple Sclerosis Research
The 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is currently being held in…
Brain-specific B Cells’ Reactivity Determines Glatiramer Acetate Therapy Success in MS Patients
In a new study entitled “The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in…
Inhibiting LINGO-1 Protein is a Potential Future Treatment for Cognitive Impairment in MS Patients
In a new study entitled “LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in experimental autoimmune…
Discovery of Mechanism That “Guides” Immune System Cells to Injury Sites Could Benefit MS Research
In a new study entitled “Neutrophil trails guide influenza-specific CD8+ T cells in the airways,” researchers uncovered…
Exclusive Breastfeeding Does Not Increase Women’s Risk for Multiple Sclerosis Relapse
In a new study entitled “Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses,” researchers investigated how…
MS Susceptibility May be Influenced by Female-Specific Variations in MicroRNAs-Coding Genes
In a new study entitled “Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity,”…
Sleep Deprivation Found To Be A Main Cause of MS-related Fatigue
In a new review entitled “Fatigue in multiple sclerosis: a look at the role of poor sleep”…
Apitope Completes Enrollment for Phase IIa Trial for Relapsing Multiple Sclerosis
Apitope, a biocompany devoted to drug discovery and development for autoimmune diseases, announced that its partner Merck Serono…
Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity
In a new study entitled “Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data”…
GM-CSF Cytokine Production Contributes to Multiple Sclerosis Development
In a recent study entitled “Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and…
New Purification Method Promises Affordable Antibody Production For Diseases Like MS
The Austrian Centre of Industrial Biotechnology (acib) developed a new purification method for pharmaceutical produced antibodies that…
Likelihood of MS, Other Autoimmune Disorders in Women Increased By Mercury in Seafood According to Study
A new study entitled “Mercury Exposure and Antinuclear Antibodies among Females of Reproductive Age in the…
New Multiple Sclerosis Society Funded Study Tests Whether Vibrating Insoles Improve Balance
A new Multiple Sclerosis pilot study was awarded a $39,000 grant by the National Multiple Sclerosis Society to investigate how patients’…
Rogue Protein Found in Alzheimer’s, Parkinson’s Also Present in Multiple Sclerosis
In a recent study entitled “Detection of protein aggregates in brain and cerebrospinal fluid derived from…
New Insights Into “T Helper Cells” Could Guide Future Multiple Sclerosis Therapies
A recent study entitled “STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is…
Experimental Multiple Sclerosis Drug Effectively Induces Remyelination in Pre-clinical Study
In a poster session at the Annual meeting of the Society for Neuroscience in Washington, ENDECE Neural presented pre-clinical…
Use of Del-1 Protein Reduces Multiple Sclerosis Severity in Mouse Study
In a study entitled “Developmental endothelial locus-1 is a homeostatic factor in the central nervous system…
Obesity Linked To Multiple Sclerosis?
A team of researchers at the Tel Aviv University report the role of obesity as a major risk factor…
MRIs are Revealing Multiple Sclerosis in Patients, Even Before Symptoms Begin
A study entitled “Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging…
Neuroprotective Qualities of Masitinib Drug in Stroke Encouraging For MS Indication
An encouraging experimental drug that is being developed for Multiple Sclerosis continues to show promise in being able to…
Experimental Multiple Sclerosis Drug Clears Key FDA Hurdle, To Be Tested in U.S.
A new human clinical trial testing the drug ATL1102 to treat Multiple Sclerosis was approved by FDA, carrying the…
IGF-1 Could Suppress Immune System in Multiple Sclerosis, Other Autoimmune Disease
Among autoimmune diseases, Multiple Sclerosis is one of the most progressive and debilitating, affecting between 300,000 and 400,000 people…
Study Finds No Link Between Vaccines and Multiple Sclerosis
A new study entitled, “Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System…
High Level of Multiple Sclerosis Diagnoses Observed Among Patients with Inflammatory Eye Disease
The first and largest study on the association between Multiple Sclerosis (MS) and Uveitis was recently presented at the…
Multiple Sclerosis Patients May Benefit From Use of Dorsiflexion Assist Orthotic, According To Research
Much of the research and development focus for treating Multiple Sclerosis revolves around pharmaceuticals. However, the development and use…
Why NAD+ Could Become a New Multiple Sclerosis Therapy
A new study entitled “NAD+ protects against EAE by regulating CD4+ T-cell differentiation” published in October…
Multiple Sclerosis Risk, Protective Factors Explored in New Research
Researchers recently uncovered some curious new insights into environmental factors that may rise or lower the risk of developing…